GlassScriptPhysician profile
Cynthia E Mayfield
NPI 1649260233
$1,542.25
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $106 · 2021: $326 · 2022: $377 · 2023: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $383.74 | 2020-2023 | Tremfya |
| Lilly USA, LLC | $220.38 | 2021-2023 | Taltz, Olumiant |
| Abbvie INC. | $202.82 | 2021-2023 | |
| Genzyme Corporation | $169.01 | 2020-2023 | |
| Regeneron Healthcare Solutions, INC. | $101.17 | 2022-2023 | Dupixent |
| Organogenesis INC. | $81.55 | 2021-2023 | Puraply |
| Amgen INC. | $76.09 | 2020-2023 | Otezla |
| Celgene Corporation | $64.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $50.45 | 2019 | |
| Ucb, INC. | $50.00 | 2019 | |
| Incyte Corporation | $48.10 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $20.72 | 2023 | Sotyktu |
| Pfizer INC. | $16.50 | 2021 | |
| Baxter Healthcare | $15.27 | 2021 | |
| Merck Sharp & Dohme LLC | $14.62 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $13.99 | 2023 | Adbry |
| Sun Pharmaceutical Industries INC. | $13.26 | 2023 | Winlevi, Absorica Ld |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Mayfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.